These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37577828)

  • 21. Efficacy of ustekinumab in palmoplantar pustulosis and palmoplantar pustular psoriasis.
    Bertelsen T; Kragballe K; Johansen C; Iversen L
    Int J Dermatol; 2014 Oct; 53(10):e464-6. PubMed ID: 24962808
    [No Abstract]   [Full Text] [Related]  

  • 22. Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study.
    Galluzzo M; Talamonti M; Atzori L; Bardazzi F; Campanati A; Di Cesare A; Diotallevi F; Flori ML; Mugheddu C; Offidani A; Piaserico S; Russo F; Sacchelli L; Bianchi L; Prignano F
    Expert Opin Biol Ther; 2022 Apr; 22(4):547-554. PubMed ID: 35043741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of IL-17 and IL-17 receptor inhibitors in the management of generalized pustular psoriasis.
    Plachouri KM; Chourdakis V; Georgiou S
    Drugs Today (Barc); 2019 Sep; 55(9):587-593. PubMed ID: 31584575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two cases of generalized pustular psoriasis successfully treated with bimekizumab.
    Hagino T; Saeki H; Kanda N
    J Dermatol; 2023 Oct; 50(10):e357-e358. PubMed ID: 37334759
    [No Abstract]   [Full Text] [Related]  

  • 25. Rapid and sustained response of acute generalized pustular psoriasis of von Zumbusch to Secukinumab.
    Wu X; Yan T; Han C; Ma L; Zeng L; Chen X; Zhang Z
    J Eur Acad Dermatol Venereol; 2023 Mar; 37(3):e338-e341. PubMed ID: 36165592
    [No Abstract]   [Full Text] [Related]  

  • 26. Pustular psoriasis appearing in a Chinese woman treated with dupilumab for atopic dermatitis: A case report.
    Zhong X; Li Y; Gao Y; Zhang Y; Lu J; Yu N; Ding Y; Shi Y
    Dermatol Ther; 2022 Nov; 35(11):e15851. PubMed ID: 36153663
    [No Abstract]   [Full Text] [Related]  

  • 27. Rapid and sustained response to spesolimab in five Chinese patients with generalized pustular psoriasis.
    Ran D; Yang B; Sun L; Wang N; Qu P; Liu J; Pan F; Wang G; Wu W; Zhang Z; Shi Z; Yang Q; Liu H; Zhang F
    Clin Exp Dermatol; 2023 Jul; 48(7):803-805. PubMed ID: 36994823
    [No Abstract]   [Full Text] [Related]  

  • 28. Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.
    Galluzzo M; D'Adamio S; Teoli M; Bianchi L; Talamonti M
    Dermatol Ther; 2019 May; 32(3):e12899. PubMed ID: 30969010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of secukinumab in moderate to severe palmoplantar pustular psoriasis over 148 weeks: Extension of the 2PRECISE study.
    Mrowietz U; Bachelez H; Burden AD; Rissler M; Sieder C; Orsenigo R; Jagiello P
    J Am Acad Dermatol; 2021 Feb; 84(2):552-554. PubMed ID: 32565211
    [No Abstract]   [Full Text] [Related]  

  • 30. Real-world data on the use of secukinumab and acitretin in pediatric generalized pustular psoriasis.
    Miao C; Chen Y; Wang Z; Xiang X; Liu Y; Xu Z
    J Dermatol; 2023 Feb; 50(2):258-261. PubMed ID: 35983654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: Results of the 2PRECISE study.
    Mrowietz U; Bachelez H; Burden AD; Rissler M; Sieder C; Orsenigo R; Chaouche-Teyara K
    J Am Acad Dermatol; 2019 May; 80(5):1344-1352. PubMed ID: 30716404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generalized pustular psoriasis: the new era of treatment with IL-36 receptor inhibitors.
    Maçães CO; Lé AM; Torres T
    J Dermatolog Treat; 2022 Nov; 33(7):2911-2918. PubMed ID: 35695278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful Secukinumab treatment of generalized pustular psoriasis and erythrodermic psoriasis.
    Mugheddu C; Atzori L; Lappi A; Pau M; Murgia S; Rongioletti F
    J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):e420-e421. PubMed ID: 28319281
    [No Abstract]   [Full Text] [Related]  

  • 34. Sustained efficacy of secukinumab in patients with moderate-to-severe palmoplantar psoriasis: 2·5-year results from GESTURE, a randomized, double-blind, placebo-controlled trial.
    Gottlieb AB; Kubanov A; van Doorn M; Sullivan J; Papp KA; You R; Regnault P; Frueh JA
    Br J Dermatol; 2020 Apr; 182(4):889-899. PubMed ID: 31286480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secukinumab retreatment associated psoriasis flare with pustules.
    El-Komy M; Amer M; Mostafa A; ElKalioby M
    J Dermatolog Treat; 2022 Mar; 33(2):1107-1110. PubMed ID: 32538223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgA nephropathy in a patient receiving infliximab for generalized pustular psoriasis.
    Segawa Y; Ishida R; Kanehisa F; Nakai K; Morimoto M; Seno M; Nakayama M; Kusaba T; Katoh N; Tamagaki K
    BMC Nephrol; 2020 Aug; 21(1):366. PubMed ID: 32842976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of ixekizumab compared to etanercept and placebo in patients with moderate-to-severe plaque psoriasis and non-pustular palmoplantar involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2 and UNCOVER-3).
    Menter A; Warren RB; Langley RG; Merola JF; Kerr LN; Dennehy EB; Shrom D; Amato D; Okubo Y; Reich K
    J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1686-1692. PubMed ID: 28322474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spesolimab: A Novel Treatment for Pustular Psoriasis.
    Ratnarajah K; Jfri A; Litvinov IV; Netchiporouk E
    J Cutan Med Surg; 2020; 24(2):199-200. PubMed ID: 32208020
    [No Abstract]   [Full Text] [Related]  

  • 39. Secukinumab-induced palmar vesiculopustular eruption in a patient with psoriasis.
    Satoh M; Yamamoto T
    Dermatol Ther; 2020 May; 33(3):e13332. PubMed ID: 32219955
    [No Abstract]   [Full Text] [Related]  

  • 40. Successful treatment with adalimumab in a patient with psoriatic arthritis and generalized pustular psoriasis.
    Kimura U; Kinoshita A; Sekigawa I; Takamori K; Suga Y
    J Dermatol; 2012 Dec; 39(12):1071-2. PubMed ID: 22506677
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.